Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 May;27(5):e70119.
doi: 10.1111/codi.70119.

Intraoperative indocyanine green fluorescence angiography in colorectal surgery to prevent anastomotic leakage: A single-blind phase III multicentre randomized controlled trial (FLUOCOL-01/FRENCH 21/GRECCAR 19 intergroup trial)

Collaborators, Affiliations

Intraoperative indocyanine green fluorescence angiography in colorectal surgery to prevent anastomotic leakage: A single-blind phase III multicentre randomized controlled trial (FLUOCOL-01/FRENCH 21/GRECCAR 19 intergroup trial)

Jean-Baptiste Pretalli et al. Colorectal Dis. 2025 May.

Abstract

Aim: Anastomotic leak (AL) is a major problem in colorectal surgery, and its prevention is crucial for patient safety. The scientific literature shows that optimal anastomotic perfusion is essential for anastomotic healing. However, in cases of left colon or rectal cancer requiring high vessel ligation for oncological reasons, anastomotic blood supply relies mainly on the pericolic arterial arcades. Consequently, assessing anastomotic perfusion using intraoperative fluorescence angiography with indocyanine green might be relevant to reduce the risk of AL. Although evidence of its positive impact on the risk of AL is growing in the literature, most studies are descriptive prospective cohorts or retrospective comparative series with controversial findings. Furthermore, no other studies specifically address left-sided colon or high rectal tumours. FLUOCOL-1 is a large multicentre randomized controlled trial (RCT) that aims to demonstrate that assessing anastomotic perfusion using intraoperative fluorescence angiography with indocyanine green will reduce ALs in left-sided or high anterior resections with intraperitoneal anastomosis METHOD: FLUOCOL-1 is a French multicentre, single-blind, randomized, two-arm, phase III superiority clinical trial. Patients will be randomized in a 1:1 ratio to either the intervention group (FLUO+) or the control group (FLUO-). A total of 1010 patients will be randomized. The primary endpoint is the occurrence of an AL within 90 days postsurgery. AL is defined as any anastomotic dehiscence with leakage into the pelvic cavity diagnosed by imaging or surgical exploration, or any isolated pelvic organ-space infection with no evidence of fistula, as defined by the International Study Group of Rectal Cancer.

Discussion: Prevention of AL is one of the most important questions to be addressed in colorectal surgery. The FLUOCOL-1 multicentre RCT described herein aims to demonstrate that assessment of anastomotic perfusion using intraoperative fluorescence angiography with indocyanine green will reduce ALs in certain resections with intraperitoneal anastomosis.

Keywords: anastomotic leakage; colic surgery; colorectal surgery; complication; fluorescence angiography; indocyanine green; prevention.

PubMed Disclaimer

Conflict of interest statement

None.

The sponsor is the owner of the data and bears responsibility for data management and analysis (Dr Vernerey, Methodology and Quality of Life Unit in Oncology).

The trial can be prematurely terminated by either the coordinating investigator or the sponsor based on medical and/or administrative reasons or the results of the interim analysis. This decision will be made after mutual consultation, with reasons for discontinuation appropriately documented and notification provided to the relevant competent authorities. The sponsor is responsible for the conduct of the trial, including covering research‐related costs, promptly reporting serious adverse events and safety monitoring.

The content of this protocol is described according to the relevant items of the SPIRIT checklist (Standard Protocol Items: Recommendations for Interventional Trials) [36].

Serb supplies the ICG (Infracyanine®) used in the study free of charge. Serb is not involved in any other part of the work, including the design or analysis of the results.

Figures

FIGURE 1
FIGURE 1
Chronology of study visits.
FIGURE 2
FIGURE 2
Decision rules for the interim and final analysis of the primary objective.

References

    1. Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209–249. 10.3322/caac.21660 - DOI - PubMed
    1. Santé publique France . Cancer du colon rectum. 2021 [cited 2021 Jul 26]. Available from: https://www.santepubliquefrance.fr/maladies‐et‐traumatismes/cancers/canc...
    1. Kingham TP, Pachter HL. Colonic anastomotic leak: risk factors, diagnosis, and treatment. J Am Coll Surg. 2009;208(2):269–278. 10.1016/j.jamcollsurg.2008.10.015 - DOI - PubMed
    1. Ashraf SQ, Burns EM, Jani A, Altman S, Young JD, Cunningham C, et al. The economic impact of anastomotic leakage after anterior resections in English NHS hospitals: are we adequately remunerating them? Colorectal Dis. 2013;15:e190–e198. 10.1111/codi.12125 - DOI - PubMed
    1. Park JS, Choi GS, Kim SH, Kim HR, Kim NK, Lee KY, et al. Multicenter analysis of risk factors for anastomotic leakage after laparoscopic rectal cancer excision: the Korean laparoscopic colorectal surgery study group. Ann Surg. 2013;257:665–671. 10.1097/SLA.0b013e31827b8ed9 - DOI - PubMed

Publication types

MeSH terms